Vaccine Traceability Chain (VTB) Latest Technology Upgrade Conference

It is understood that Vaccine traceability chain (VTB) and GlaxoSmithKline (Malta) Limited (GlaxoSmithKline (Malta) previously reached a strategic cooperation agreement. The two sides conducted clinical tests on the application of VTB. After several months of practical testing, the two parties recently Achieve deeper and long-term cooperation. The VTB co-founding fund stated that this cooperation proves the important role of VTB in the medical field and will negotiate cooperation with more large medical institutions around the world.

According to GlaxoSmithKline (Malta) Limited CEO Emma Walmsley (Emma Walmsley) said: Vaccine Traceability Chain (VTB) makes full use of blockchain distributed accounting, open, transparent, non-tamperable and traceable technologies Features, detailed the overall monitoring of the vaccine supply chain in an all-round way. It has realized the traceability of the whole process of vaccine from raw material production, sales, cold chain storage and transportation to vaccination. The emergence of VTB technology has changed the vaccine safety problems, cold chain storage problems and the difficult situation of accountability that have repeatedly appeared in the field of vaccines in traditional medical systems, and has made a revolutionary contribution to the safety of the global smart medical system.

With the promotion of VTB to global medical institutions, (VTB) has entered a new chapter. The VTB co-founded fund is currently actively seeking to list on more cryptocurrency exchanges around the world, and has received invitations from many exchanges including the top 10 international exchanges. It can also prove that VTB blockchain technology will have broader prospects in the future. In addition, the VTB Foundation stated that it will start the A-round financing plan on 4.15, and the total financing will account for 27% of the total issuance

At present, just like the growth process of BTC and ETH, VTB blockchain technology is maturing rapidly. According to the analysis and comments of Citigroup, Morgan, Wells Fargo, Standard Chartered Bank, CoinNess, Japan SBI Holdings and other world-renowned institutions on the VTB technology, its security and flexibility will reach an unprecedented level. From a comprehensive analysis, it is self-listing VTB technology has been rising steadily since. The current price is about US$80, and the future price of VTB is about US$800, which is a normal valuation. The market value is approximately US$80 billion.